Zhongjin Liu, Wei Qin, Tao Peng. "Efficacy and safety of transarterial therapy combined with donafenib plus programmed cell death protein-1 inhibitors for unresectable hepatocellular carcinoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16210